Low-dose apixaban in HeartMate 3 LVAD patients, interim analysis of the ApixiVAD trial, a randomized controlled study

This publication has 25 references indexed in Scilit:

• Antithrombotic Strategies With Left Ventricular Assist Devices
  Journal of Cardiac Failure, 2024
• Direct Oral Anticoagulant Therapy With A Fully Magnetically Levitated LVAD and Bridging to Heart Transplantation: A DOT-HM3 Study Analysis
  Journal of Cardiac Failure, 2024
• Apixaban in Bridge to Transplant and Destination LVAD - Rationale and Study Design: The ApixiVAD Trial
  ESC Heart Failure, 2024
• Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure
  JAMA, 2023
• (829) Self-Management if Anticoagulation in Patients with Lvad, is There a Cost to Anticoagulation on Target?
  The Journal of Heart and Lung Transplantation, 2023
• Maximising Time in Therapeutic Range with Vitamin K Antagonists in LVAD Patients
  The Journal of Heart and Lung Transplantation, 2021
• Bloody Transplants! Impact of Prior Sternotomy on Transfusion Rate in Heart Transplantation
  The Journal of Heart and Lung Transplantation, 2021
• Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry
  The Journal of Heart and Lung Transplantation, 2019
• Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study
  The Journal of Heart and Lung Transplantation, 2018
• Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump—the MAGENTUM 1 study
  The Journal of Heart and Lung Transplantation, 2018